This study aimed at analyzing the alimentary habits of treated hypertensive patients identifying the degree of concordance with Dietary Approaches to Stop Hypertension (DASH) plan. Anthropometry and blood pressure (BP) were evaluated, and the 10-year risk for general cardiovascular disease was estimated and used to calculate vascular age. A DASH concordance score was obtained using food frequency questionnaire and the cut-off points were established for eight food groups. Subjects were divided into two groups according to the median of DASH concordance score: lower concordance (LC group < 4.5 points, ) and higher concordance (HC group ≥ 4.5 points, ). LC group was associated with higher BP, vascular age, and cardiovascular risk. DASH concordance score was positively correlated with intake of fiber, calcium, potassium, and magnesium ( ) and negatively correlated with BP, cardiovascular risk, and vascular age ( ). After logistic regression adjusted for age and gender, only cardiovascular risk ( , ) was independently associated with DASH concordance score. Hypertensive patients with dietary patterns less concordant with the DASH plan had higher BP levels and increased cardiovascular risk, indicating the relevance of management in the treatment of these patients. 1. Introduction The adoption of a healthy lifestyle, with a reduced dietary fat and salt intake, is one of the main actions that must be implemented in hypertensive patients [1, 2]. The Dietary Approaches to Stop Hypertension (DASH) plan has been recognized among the numerous recommendations regarding nonpharmacological management for reducing blood pressure (BP) levels. The DASH diet encourages the increased consumption of foods containing fibers, protein, calcium, potassium, and magnesium and the restriction of cholesterol, total, and saturated fat. Thus, a greater intake of fruits, vegetables, grains, low-fat dairy products, nuts, legumes, and lean meats has been suggested, along with a reduction in the consumption of fat, red meat, sweets, and sugar-containing beverages [3]. The exact mechanism of action related to the DASH plan is not completely elucidated. Combined foods according to this eating plan may provide an important strategy to control BP especially in the prehypertensive stage (systolic BP 120–139？mmHg and/or diastolic BP 80–89？mmHg) or stage I hypertension (systolic BP 140–159？mmHg and/or diastolic BP 90–99？mmHg). However, the role of these dietary factors, alone or in combination, in BP regulation remains controversial [4]. Other potential benefits of the DASH diet include
References
[1]
E. Matyas, K. Jeitler, K. Horvath et al., “Benefit assessment of salt reduction in patients with hypertension: systematic overview,” Journal of Hypertension, vol. 29, no. 5, pp. 821–828, 2011.
[2]
D. Zhao, Y. Qi, Z. Zheng, et al., “Dietary factors associated with hypertension,” Nature Reviews Cardiology, vol. 8, no. 8, pp. 456–465, 2011.
[3]
National Heart Lung and Blood Institute , “Your guide to lowering your blood pressure with DASH,” 2006, http://www.nhlbi.nih.gov/health/public/heart/hbp/dash/new_dash.pdf.
[4]
H. Nguyen, O. A. Odelola, J. Rangaswami, et al., “A review of nutritional factors in hypertension management,” International Journal of Hypertension, vol. 2013, pp. 1–12, 2013.
[5]
J. A. Blumenthal, M. A. Babyak, A. Hinderliter et al., “Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: The ENCORE study,” Archives of Internal Medicine, vol. 170, no. 2, pp. 126–135, 2010.
[6]
L. Azadbakht, N. R. P. Fard, M. Karimi et al., “Effects of the Dietary Approaches to Stop Hypertension (DASH) eating plan on cardiovascular risks among type 2 diabetic patients: a randomized crossover clinical trial,” Diabetes Care, vol. 34, no. 1, pp. 55–57, 2011.
[7]
T. T. Fung, S. E. Chiuve, M. L. McCullough, K. M. Rexrode, G. Logroscino, and F. B. Hu, “Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women,” Archives of Internal Medicine, vol. 168, no. 7, pp. 713–720, 2008.
[8]
K. C. Fitzgerald, S. E. Chiuve, J. E. Buring, P. M. Ridker, and R. J. Glynn, “Comparison of associations of adherence to a Dietary Approaches to Stop Hypertension (DASH)-style diet with risks of cardiovascular disease and venous thromboembolism,” Journal of Thrombosis and Haemostasis, vol. 10, no. 2, pp. 189–198, 2012.
[9]
R. Sichieri and J. E. Everhart, “Validity of a Brazilian food frequency questionnaire against dietary recalls and estimated energy intake,” Nutrition Research, vol. 18, no. 10, pp. 1649–1659, 1998.
[10]
K. M. Ryder, R. I. Shorr, A. J. Bush et al., “Magnesium intake from food and supplements is associated with bone mineral density in healthy older white subjects,” Journal of the American Geriatrics Society, vol. 53, no. 11, pp. 1875–1880, 2005.
[11]
Núcleo de Estudos e Pesquisa em Alimenta？？o and Universidade Estadual de Campinas, Brazilian Table of Food Composition, 2011.
[12]
R. B. D'Agostino Sr., R. S. Vasan, M. J. Pencina et al., “General cardiovascular risk profile for use in primary care: The Framingham Heart Study,” Circulation, vol. 117, no. 6, pp. 743–753, 2008.
[13]
E. B. Levitan, A. Wolk, and M. A. Mittleman, “Consistency with the DASH diet and incidence of heart failure,” Archives of Internal Medicine, vol. 169, no. 9, pp. 851–857, 2009.
[14]
P. W. Siri-Tarino, Q. Sun, F. B. Hu, and R. M. Krauss, “Saturated fat, carbohydrate, and cardiovascular disease,” American Journal of Clinical Nutrition, vol. 91, no. 3, pp. 502–509, 2010.
[15]
Z. Zhang, G. Xu, D. Liu, et al., “Dietary fiber consumption and risk of stroke,” European Journal of Epidemiology, vol. 28, no. 2, pp. 119–130, 2013.
[16]
R. Estruch, M. A. Martínez-González, D. Corella et al., “Effects of dietary fibre intake on risk factors for cardiovascular disease in subjects at high risk,” Journal of Epidemiology and Community Health, vol. 63, no. 7, pp. 582–588, 2009.
[17]
Y. Al-Solaiman, A. Jesri, W. K. Mountford, D. T. Lackland, Y. Zhao, and B. M. Egan, “DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre,” Journal of Human Hypertension, vol. 24, no. 4, pp. 237–246, 2010.
[18]
A. R. Folsom, E. D. Parker, and L. J. Harnack, “Degree of Concordance With DASH Diet Guidelines and Incidence of Hypertension and Fatal Cardiovascular Disease,” American Journal of Hypertension, vol. 20, no. 3, pp. 225–232, 2007.
[19]
M. O. D. Sabry, H. A. D. C. Sampaio, and M. G. C. D. Silva, “Consumo alimentar de indivíduos hipertensos: uma compara？？o com o Plano DASH (Dietary Approaches to Stop Hypertension),” Revista Brasileira de Nutri？？o Clínica, vol. 22, no. 2, pp. 121–126, 2007.
[20]
E. B. Levitan, J. M. Shikany, A. Ahmed, et al., “Calcium, magnesium and potassium intake and mortality in women with heart failure: the Women's Health Initiative,” British Journal of Nutrition, vol. 110, no. 1, pp. 179–185, 2013.
[21]
F. M. Sacks, L. P. Svetkey, W. M. Vollmer et al., “Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet,” The New England Journal of Medicine, vol. 344, no. 1, pp. 3–10, 2001.
[22]
G. Simon, “Experimental evidence for blood pressure-independent vascular effects of high sodium diet,” American Journal of Hypertension, vol. 16, no. 12, pp. 1074–1078, 2003.
[23]
N. R. Cook, E. Obarzanek, J. A. Cutler et al., “Joint effects of sodium and potassium intake on subsequent cardiovascular disease: the trials of hypertension prevention follow-up study,” Archives of Internal Medicine, vol. 169, no. 1, pp. 32–40, 2009.
[24]
E. D. Frohlich and J. Varagic, “The role of sodium in hypertension is more complex than simply elevating arterial pressure,” Nature Clinical Practice Cardiovascular Medicine, vol. 1, no. 1, pp. 24–30, 2004.
[25]
L. J. Appel, “Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER Clinical Trial,” Journal of the American Medical Association, vol. 289, no. 16, pp. 2083–2093, 2003.
